Credo Technology tumbles after issuing mediocre guidance

Trending Society Staff·Reviewed byJeff Liu··5 min read·Finance
Credo Technology tumbles after issuing mediocre guidance

The latest earnings reports have painted a complex picture for investors, revealing significant volatility driven by company-specific guidance, geopolitical events, and evolving technological trends. While some firms saw their stocks tumble on cautious outlooks or accounting missteps, others defied profit warnings with strong revenues or unexpected political tailwinds, showcasing a market highly sensitive to forward-looking statements and regulatory shifts.

Navigating the Post-Market Swings: Dissecting Recent Earnings Reactions

The recent earnings season has delivered a mixed bag of corporate performance and market reactions, highlighting how investor sentiment can pivot dramatically on guidance and unexpected news. Several companies experienced significant after-hours trading volatility as markets digested their latest financial disclosures.

Credo Technology's Mixed Signal

Connectivity solutions provider, Credo Technology Group (CRDO), saw its shares tumble double digits in postmarket trading, ultimately dropping 5% after-hours. This slide occurred despite a strong third quarter, where the company posted revenues of [SOURCE:Original]$407 million[/SOURCE], exceeding analyst estimates of $406.4 million. Adjusted earnings per share also beat expectations, coming in at [SOURCE:Original]$1.07[/SOURCE] against a $0.92 estimate.

The culprit for the stock's decline was its guidance for the current fourth quarter. Management projected sales between $425 million and $435 million, with the midpoint modestly below Wall Street's $430.5 million call. More specifically, the forecast for non-GAAP gross margin, ranging from 64% to 66%, fell short of the LSEG consensus estimate of 65.1%. However, it wasn't all negative: Credo's adjusted EBITDA guidance of $290 million to $305 million significantly surpassed the $252.7 million estimate, and its full-year revenue guidance of $690 million to $710 million was well above the $637.6 million forecast.

Plug Power Powers Ahead Despite Charges

Hydrogen fuel cell company, Plug Power (PLUG), experienced a postmarket surge despite reporting significant losses. The company's shares rallied after it announced robust fourth-quarter sales that surpassed analyst expectations. Plug Power reported revenues of [SOURCE:Original]$225.22 million[/SOURCE], comfortably beating the estimate of $217.26 million.

While adjusted earnings per share were still negative at [SOURCE:Original]-$0.06[/SOURCE], this was better than the -$0.10 expected by analysts. The quarter was impacted by [SOURCE:Original]$763 million[/SOURCE] in "various net charges," which significantly worsened other earnings metrics. Despite these substantial charges, management reaffirmed its ambitious goal of achieving positive EBITDAS (earnings before interest, taxes, depreciation, amortization, and stock-based compensation) by 2026, stating the company is "positioned" to do so.

Core Scientific's Accounting Correction and Revenue Miss

Bitcoin miner turned data center company, Core Scientific, saw its shares sink in postmarket trading after a disappointing fourth-quarter sales report and an unexpected accounting disclosure. The company reported revenues of [SOURCE:Original]$79.8 million[/SOURCE], considerably lower than the $115 million analysts had anticipated. Both its self-mining and high-performance computing hosting divisions underperformed sales expectations.

Adding to investor concerns, Core Scientific also revealed an accounting error, stating it had overstated the value of property, plant, and equipment. This error necessitates the restatement of several previous financial releases. However, the company assured investors that [SOURCE:Original]these changes do not affect revenue, adjusted EBITDA, or net cash flows[/SOURCE]. In Q4, Core Scientific shareholders also rejected an offer from CoreWeave to purchase the company, an acquisition that would have created a more vertically integrated neocloud provider.

Archer Aviation's Flight Plan Faces Headwinds

Air taxi manufacturer Archer Aviation (ACHR) reported a deeper-than-expected loss for its fourth quarter. The company posted a [SOURCE:Original]loss of $0.26 per share[/SOURCE], compared to the $0.24 loss per share anticipated by FactSet-polled analysts. Following the announcement, Archer's shares dipped 2.4% after hours, partially eroding the gains made during the regular trading session.

Despite the quarterly loss, Archer ended 2025 with a significant cash position of [SOURCE:Original]$1.96 billion[/SOURCE], an increase from $1.64 billion in Q3 and $834.5 million in the same quarter the previous year. Looking ahead to Q1, Archer anticipates adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) to be between [SOURCE:Original]-$160 million and -$180 million[/SOURCE], which is wider than Wall Street's expectation of -$104.7 million. On the strategic front, Archer recently announced a partnership with SpaceX’s Starlink to integrate satellite internet into its Midnight aircraft and aims for its first passenger flights this year. CEO Adam Goldstein highlighted the defense business as a "front and center" division for the next decade, with a partnership with Anduril at the core of this strategy, focusing on a dual-use autonomous, hybrid-electric VTOL (vertical take-off and landing) aircraft.

Hims & Hers Soars on Peptide Promise

Digital health company Hims & Hers (HIMS) saw its stock surge amid unexpected commentary from Robert F. Kennedy Jr., the Health and Human Services Secretary. During an appearance on the "Joe Rogan Experience" podcast, [SOURCE:Original]RFK Jr. expressed his desire[/SOURCE] to make approximately 14 peptides more accessible and allow for their compounding, indicating that the FDA is actively reviewing the science behind these treatments.

Peptides are short chains of amino acids that regulate various bodily processes and are the active ingredients in popular GLP-1 medications used for diabetes and weight loss. A more permissive regulatory stance toward these compounds could potentially unlock substantial new revenue opportunities for Hims & Hers. The company has faced significant "legal and regulatory apparatus" as a headwind in 2026, and these remarks signal a potential shift in the regulatory environment.

Broader Market Dynamics: Geopolitics and the AI Frenzy

Beyond individual company results, broader market forces continue to shape investor decisions. Defense and oil stocks saw gains after the U.S. launched a series of attacks against Iran [SOURCE:Original]. Conversely, fuel-reliant travel assets experienced declines in response to these geopolitical tensions, reflecting immediate market sensitivity to global events.

Meanwhile, the pervasive influence of artificial intelligence continues to drive market narratives, with investors keenly searching for both winners and potential "shakeouts" in the sector. While some companies linked to AI, like Nvidia, saw their shares rise , others such as Workday (wsj.com)pared losses after issuing weaker-than-expected guidance, fueling concerns over increased AI competition. Skeptical traders are actively seeking ways to bet against the current AI frenzy, anticipating an eventual market correction .

Related Articles

More insights on trending topics and technology

Newsletter

Stay informed without the noise.

Daily AI updates for builders. No clickbait. Just what matters.